In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Repligen acquires Atoll

Executive Summary

Repligen Corp acquired German chromatography column manufacturer Atoll GMBH from UV-Cap GMBH for $9.1mm in cash and 538.7k shares--a total of $22.5mm. Repligen could also pay a sales milestone of $1.1mm.
Deal Industry
  • Biotechnology
    • Synthesis Technologies, Production Processes
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Stock
    • Acquisition of Private Biotech
    • Payment Includes Cash
    • Full Acquisition
    • Includes Earnout

Related Companies

Advertisement
UsernamePublicRestriction

Register